The barer of sad news
The Scottish Medicines Consortium (SMC) make recommendations on the use of medicines which is separate to NICE. Roche anticipate submitting OCREVUS to the SMC for PPMS in the very near future, and anticipate that the SMC process will conclude towards the end of 2019/early 2020.
@watsoncraig , I can't see that Nicola would allow the situation to drag on - it wouldn't fit with her master plan! 😉